MedTrace Logo

The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program

NCT05832307 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22000

Last updated 2026-04-08

No results posted yet for this study

Summary

This study plans to learn more about whether a stakeholder-informed, standardized inpatient vaccination program will increase influenza vaccination rates of hospitalized children across US pediatric health systems. The first part of the study is to form a multidisciplinary team of stakeholders, including parents, providers, nurses, pharmacists, informaticists, data analysts and communication experts across three sites in synthesizing a best practice implementation guide for an inpatient influenza vaccination program, which will then be piloted at these three sites.

Conditions

Interventions

OTHER

Existing Influenza Vaccination Practices

Usual care is defined as the existing inpatient influenza vaccination practices that currently exist at a given site.

OTHER

Standardized inpatient influenza vaccination program

Intervention A: The basic intervention is the inpatient influenza vaccination program Intervention B: The intensified intervention is the multifaceted influenza vaccination strategy (Intervention A) plus a learning collaborative

Sponsors & Collaborators

  • Agency for Healthcare Research and Quality (AHRQ)

    collaborator FED

  • Seattle Children's Hospital

    collaborator OTHER

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Suchitra Rao · University of Colorado, Children's Hospital Colorado

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
6 Months
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-31
Primary Completion
2027-07-31
Completion
2027-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05832307 on ClinicalTrials.gov